felodipine has been researched along with Goldblatt Syndrome in 6 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The new calcium antagonist felodipine with a pronounced arteriolar dilating capacity was used to treat 11 patients with severe hypertension resistant to treatment (4 with essential hypertension, 5 with renoparechymatous hypertension, 2 with renovascular hypertension)." | 3.67 | Renal effects of felodipine in hypertensive patients with reduced renal function. ( Aurell, M; Björck, S; Granérus, G; Herlitz, H, 1985) |
| "To explore the effect of puerarin combined with felodipine on the mRNA and protein expression of apelin and APJ in renal tissue of renovascular hypertensive rat." | 1.39 | [Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]. ( Bai, S; Chen, L; Ding, BP; Huang, ZG; Wang, JT, 2013) |
| "This felodipine effect was stronger and longer lasting than the nifedipine one." | 1.28 | [Antihypertensive effect of felodipine, a new calcium antagonist]. ( Hayashi, S; Inoue, T; Inukai, T; Nakao, K; Odagiri, N; Omosu, M; Ono, T; Sakaguchi, S, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, S | 2 |
| Huang, ZG | 2 |
| Chen, L | 2 |
| Wang, JT | 2 |
| Ding, BP | 2 |
| Wu, TH | 1 |
| Tsai, SH | 1 |
| Tsai, CY | 1 |
| Huang, TP | 1 |
| Inoue, T | 1 |
| Omosu, M | 1 |
| Hayashi, S | 1 |
| Sakaguchi, S | 1 |
| Nakao, K | 1 |
| Inukai, T | 1 |
| Odagiri, N | 1 |
| Ono, T | 1 |
| Jackson, B | 1 |
| Johnston, CI | 1 |
| Herlitz, H | 1 |
| Aurell, M | 1 |
| Björck, S | 1 |
| Granérus, G | 1 |
6 other studies available for felodipine and Goldblatt Syndrome
| Article | Year |
|---|---|
Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Drug Therapy, Combination; Felodipine; Hype | 2013 |
[Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat].
Topics: Animals; Antihypertensive Agents; Apelin; Apelin Receptors; Blotting, Western; Captopril; Drug Syner | 2013 |
Renovascular hypertension after laparoscopic adrenalectomy in a patient with adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Antihypertensive Agents; Arteri | 1996 |
[Antihypertensive effect of felodipine, a new calcium antagonist].
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Di | 1992 |
The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Enalapr | 1988 |
Renal effects of felodipine in hypertensive patients with reduced renal function.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Felodipine; Female; Glomerular Filtration Rate | 1985 |